Patent · US Active

Compositions and methods of treatment

US11466292B2 · kind B2 · utility

0Cited by

0References

20Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Wivine Burny · Rixensart, BE
Cindy Castado · Rixensart, BE
Sandra Giannini · Rixensart, BE
Julien Thierry Massaux · Rixensart, BE

Key dates

Filing date	Sep 27, 2017
Grant date	Oct 11, 2022
Priority date	—
Expiry date	Sep 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2710/20034
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to nucleic acid constructs capable of encoding antigenic peptides or polypeptides derived from multiple Human Papilloma Virus (HPV) early proteins, and to immunogenic compositions comprising such nucleic acid constructs and a pharmaceutically acceptable carrier. Such nucleic acid constructs and immunogenic compositions are useful in the treatment of persistent HPV infection and low-grade HPV lesions, particularly infections and lesions of human anogenital epithelial tissue, such as cervical epithelia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.